Company Filing History:
Years Active: 2022
Title: Inji Shin: Innovator in Cancer Treatment
Introduction
Inji Shin is a prominent inventor based in Daejeon, South Korea. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative treatments for cancer. Her work focuses on creating compounds that can effectively target specific mutations associated with cancer.
Latest Patents
Inji Shin holds a patent for a compound known as N2,N4-diphenylpyrimidine-2,4-diamine derivative. This invention includes a method for preparing the compound and a pharmaceutical composition that utilizes it as an active ingredient for the prevention or treatment of cancer. The derivative demonstrates a relatively weak inhibitory effect on wild-type EGFR but shows a high inhibitory ability on EGFR mutations, as well as on FLT3 and its mutations. This makes it a promising candidate for treating cancers associated with these mutations, especially when used in combination therapies.
Career Highlights
Inji Shin is affiliated with the Korea Research Institute of Chemical Technology, where she conducts her research and development activities. Her work has been instrumental in advancing the understanding of cancer treatment options and the development of new therapeutic agents.
Collaborations
Inji Shin collaborates with notable colleagues, including Kwangho Lee and Gildon Choi. Their combined expertise enhances the research efforts at the Korea Research Institute of Chemical Technology, leading to innovative solutions in cancer treatment.
Conclusion
Inji Shin's contributions to cancer research through her patented inventions highlight her role as a key innovator in the pharmaceutical field. Her work not only advances scientific knowledge but also offers hope for effective cancer treatments.